BIOMAT Database Logo BIOMAT Database Logo

Non-alcoholic fatty liver disease concerns with glucokinase activators - Authors' reply. 2018

Xiaoying Li, and Li Chen
Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

UI MeSH Term Description Entries
D005941 Glucokinase A group of enzymes that catalyzes the conversion of ATP and D-glucose to ADP and D-glucose 6-phosphate. They are found in invertebrates and microorganisms, and are highly specific for glucose. (Enzyme Nomenclature, 1992) EC 2.7.1.2.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D065626 Non-alcoholic Fatty Liver Disease Fatty liver finding without excessive ALCOHOL CONSUMPTION. Fatty Liver, Nonalcoholic,NAFLD,Nonalcoholic Fatty Liver Disease,Nonalcoholic Steatohepatitis,Fatty Livers, Nonalcoholic,Liver, Nonalcoholic Fatty,Livers, Nonalcoholic Fatty,Non alcoholic Fatty Liver Disease,Nonalcoholic Fatty Liver,Nonalcoholic Fatty Livers,Nonalcoholic Steatohepatitides,Steatohepatitides, Nonalcoholic,Steatohepatitis, Nonalcoholic

Related Publications

Xiaoying Li, and Li Chen
Non-alcoholic fatty liver disease concerns with glucokinase activators.
September 2018, The lancet. Diabetes & endocrinology,
Xiaoying Li, and Li Chen
Letter: hereditary role in non-alcoholic fatty liver disease - authors' reply.
January 2023, Alimentary pharmacology & therapeutics,
Xiaoying Li, and Li Chen
Non-alcoholic fatty liver disease and the risk of dementia-Authors' reply.
August 2022, Liver international : official journal of the International Association for the Study of the Liver,
Xiaoying Li, and Li Chen
Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity-authors' reply.
August 2017, Alimentary pharmacology & therapeutics,
Xiaoying Li, and Li Chen
Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply.
March 2013, Alimentary pharmacology & therapeutics,
Xiaoying Li, and Li Chen
Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease. Authors' reply.
July 2020, Alimentary pharmacology & therapeutics,
Xiaoying Li, and Li Chen
Letter: association between moderate alcohol consumption and non-alcoholic fatty liver disease--authors' reply.
December 2015, Alimentary pharmacology & therapeutics,
Xiaoying Li, and Li Chen
A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators.
September 2014, Journal of gastrointestinal and liver diseases : JGLD,
Xiaoying Li, and Li Chen
Letter: association of circulating bile acid concentrations and non-alcoholic fatty liver disease-authors' reply.
July 2022, Alimentary pharmacology & therapeutics,
Xiaoying Li, and Li Chen
Letter: gender-associated cell-free microRNA profiles in non-alcoholic fatty liver disease--authors' reply.
May 2014, Alimentary pharmacology & therapeutics,
Copied contents to your clipboard!